BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29860411)

  • 1. Chronic Opioid Therapy in People Living With Human Immunodeficiency Virus: Patients' Perspectives on Risks, Monitoring, and Guidelines.
    Colasanti J; Lira MC; Cheng DM; Liebschutz JM; Tsui JI; Forman LS; Sullivan M; Walley AY; Bridden C; Root C; Podolsky M; Abrams C; Outlaw K; Harris CE; Armstrong WS; Samet JH; Del Rio C
    Clin Infect Dis; 2019 Jan; 68(2):291-297. PubMed ID: 29860411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
    Turner JA; Saunders K; Shortreed SM; LeResche L; Riddell K; Rapp SE; Von Korff M
    J Gen Intern Med; 2014 Dec; 29(12):1663-71. PubMed ID: 25217208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provider opioid prescribing practices and the belief that opioids keep people living with HIV engaged in care: a cross-sectional study.
    Tsui JI; Walley AY; Cheng DM; Lira MC; Liebschutz JM; Forman LS; Sullivan MM; Colasanti J; Root C; O'Connor K; Shanahan CW; Bridden CL; Del Rio C; Samet JH
    AIDS Care; 2019 Sep; 31(9):1140-1144. PubMed ID: 30632790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives.
    Von Korff M; Walker RL; Saunders K; Shortreed SM; Thakral M; Parchman M; Hansen RN; Ludman E; Sherman KJ; Dublin S
    Int J Drug Policy; 2017 Aug; 46():90-98. PubMed ID: 28666143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.
    Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK
    Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting.
    Brown J; Setnik B; Lee K; Wase L; Roland CL; Cleveland JM; Siegel S; Katz N
    J Opioid Manag; 2011; 7(6):467-83. PubMed ID: 22320029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
    Turner JA; Saunders K; Shortreed SM; Rapp SE; Thielke S; LeResche L; Riddell KM; Von Korff M
    J Gen Intern Med; 2014 Feb; 29(2):305-11. PubMed ID: 24142119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timeliness of Care Planning upon Initiation of Chronic Opioid Therapy for Chronic Pain.
    Von Korff M; Turner JA; Shortreed SM; Saunders K; Rosenberg D; Thielke S; LeResche L
    Pain Med; 2016 Mar; 17(3):511-520. PubMed ID: 26814284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
    Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
    Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doctor-Patient Trust Among Chronic Pain Patients on Chronic Opioid Therapy after Opioid Risk Reduction Initiatives: A Survey.
    Sherman KJ; Walker RL; Saunders K; Shortreed SM; Parchman M; Hansen RN; Thakral M; Ludman EJ; Dublin S; Von Korff M
    J Am Board Fam Med; 2018; 31(4):578-587. PubMed ID: 29986984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hazardous alcohol use is associated with greater pain interference and prescription opioid misuse among persons living with HIV and chronic pain.
    Ngo B; Liebschutz JM; Cheng DM; Colasanti JA; Merlin JS; Armstrong WS; Forman LS; Lira MC; Samet JH; Del Rio C; Tsui JI
    BMC Public Health; 2021 Mar; 21(1):564. PubMed ID: 33752634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial.
    Samet JH; Tsui JI; Cheng DM; Liebschutz JM; Lira MC; Walley AY; Colasanti JA; Forman LS; Root C; Shanahan CW; Sullivan MM; Bridden CL; Abrams C; Harris C; Outlaw K; Armstrong WS; Del Rio C
    Clin Infect Dis; 2021 Oct; 73(7):e2052-e2058. PubMed ID: 32697847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality After Discontinuation of Primary Care-Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study.
    James JR; Scott JM; Klein JW; Jackson S; McKinney C; Novack M; Chew L; Merrill JO
    J Gen Intern Med; 2019 Dec; 34(12):2749-2755. PubMed ID: 31468341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of patient trust in provider and health literacy on receipt of guideline-concordant chronic opioid therapy in HIV care settings.
    Williams EC; Frost MC; Lodi S; Forman LS; Lira MC; Tsui JI; Lunze K; Kim T; Liebschutz JM; Rio CD; Samet JH
    J Opioid Manag; 2023; 19(5):385-393. PubMed ID: 37968972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Chronic Opioid Therapy Risk Reduction Initiatives on Opioid Overdose.
    Von Korff M; Saunders K; Dublin S; Walker RL; Thakral M; Sherman KJ; Ludman EJ; Hansen RN; Parchman M; Shortreed SM
    J Pain; 2019 Jan; 20(1):108-117. PubMed ID: 30189248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
    Setnik B; Roland CL; Pixton GC; Sommerville KW
    Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Future Chronic Opioid Use Among Hospitalized Patients.
    Calcaterra SL; Scarbro S; Hull ML; Forber AD; Binswanger IA; Colborn KL
    J Gen Intern Med; 2018 Jun; 33(6):898-905. PubMed ID: 29404943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.